Pfizer

Pfizer Enterprise Value

The Enterprise Value (EV) of Pfizer (PFIZER.NS) as of Oct 3, 2026 is 193.83 B INR. In the previous year, Enterprise Value (EV) was 201.24 B INR — a change of -3.68% (lower).

Enterprise Value

193.83 BINR

YoY

-3.68%

Last updated:

Enterprise Value (EV) of Pfizer is 2026 193.83 B INR. Enterprise Value (EV) of Pfizer was 2025 201.24 B INR. It decreases by -3.68% lower compared to the previous year.

The Pfizer Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2018
203.17 B INR
Jan 1, 2019
201.74 B INR
Jan 1, 2020
199.94 B INR
Jan 1, 2021
210.67 B INR
Jan 1, 2022
206.10 B INR
Jan 1, 2023
203.51 B INR
Jan 1, 2024
201.24 B INR
Jan 1, 2025
193.83 B INR
The Pfizer Enterprise Value history
YEAREnterprise ValueYoY
193.83 BINR-3.68%
201.24 BINR-1.12%
203.51 BINR-1.25%
206.10 BINR-2.17%
210.67 BINR+5.37%
199.94 BINR-0.89%
201.74 BINR-0.70%
203.17 BINR-1.21%
205.66 BINR-2.37%
210.65 BINR-1.90%
214.74 BINR-1.36%
217.70 BINR—
Access this data via the Eulerpool API

Pfizer Stock analysis

What does Pfizer do? Pfizer Ltd is a global biopharmaceutical company based in New York City, USA. The company was founded in 1849 by cousins Charles Pfizer and Charles Erhart, and has achieved numerous milestones in the pharmaceutical industry during its 170-year history. Pfizer's business model is based on the research, development, production, and distribution of innovative drugs and vaccines for a variety of diseases. With a diverse portfolio of products, the company's range extends from drugs for cancer, inflammation, and immunology to neurological and cardiology conditions. Pfizer is a global leader in the development of cancer drugs and has achieved groundbreaking research successes in recent years. Key divisions of the company include oncology, pain management, cardiology, and neurology. Pfizer places great emphasis on putting patients and their needs at the center and works closely with medical professionals, patient groups, and authorities to ensure the best possible patient care. Pfizer is a leading provider of vaccines and has achieved significant breakthroughs in the development of COVID-19 vaccines in recent years. In December 2020, the company was one of the first worldwide to bring a vaccine against the coronavirus to market, making a significant contribution to the fight against the pandemic. In addition to drug research and development, Pfizer is also heavily involved in corporate social responsibility. The company is committed to sustainable development and continuously works to reduce its carbon footprint. The Pfizer Foundation also supports numerous nonprofit organizations and projects in the areas of health, education, and environmental protection. Among Pfizer's most well-known products are medications such as Viagra, Lipitor, and Lyrica, as well as the COVID-19 vaccine Comirnaty. Pfizer has offices in over 150 countries and employs over 90,000 people worldwide. Like any global company, Pfizer faces challenges. The company is often criticized for high drug prices and the availability of medications in developing countries. However, Pfizer actively advocates for access to affordable healthcare and delivers drugs and vaccines to all regions of the world. Overall, Pfizer is a company of great importance in the global healthcare industry. Through its research and development of innovative drugs and vaccines, the company contributes to improving the quality of life for millions of people worldwide. Pfizer is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pfizer stock

Enterprise Value (EV) of Pfizer is 193.83 B INR in 2026.

Enterprise Value (EV) of Pfizer changed from 201.24 B INR to 193.83 B INR, representing a -3.68% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Pfizer since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s INR, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' INR varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Pfizer with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Pfizer

All Key Metrics — Pfizer